Alder BioPharma (ALDR) Misses Q3 EPS by 11c

Alder BioPharma (NASDAQ: ALDR) reported Q3 EPS of ($0.62), $0.11 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c